Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership
All 13F 13D/G Other
Tags CC transcript
|
GSK plc (GSK)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/10/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
05/16/2023 |
SC 13D/A
| GSK plc reports a 10.9% stake in Haleon plc |
01/20/2023 |
SC 13D/A
| GSK PLC reports a 12.2% stake in 23ANDME HOLDING CO. |
01/20/2023 |
SC 13D/A
| GSK PLC reports a 17.8% stake in SPERO THERAPEUTICS, INC. |
11/14/2022 |
SC 13D/A
| GSK PLC reports a 20% stake in SPERO THERAPEUTICS, INC. |
09/20/2022 |
SC 13D/A
| GSK PLC reports a 0% stake in THERAVANCE BIOPHARMA, INC. |
08/03/2022 |
SC 13D/A
| GSK PLC reports a 12.7% stake in THERAVANCE BIOPHARMA, INC. |
05/13/2022 |
SC 13D/A
| GSK PLC reports a 6.8% stake in Nkarta, Inc. |
02/10/2022 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 13.1% stake in THERAVANCE BIOPHARMA, INC. |
09/16/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 5.4% stake in SPERO THERAPEUTICS, INC. |
09/16/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 6% stake in BICYCLE THERAPEUTICS PLC |
05/25/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 0% stake in INNOVIVA, INC. |
04/16/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC has filed a Schedule 13D for BICYCLE THERAPEUTICS PLC |
04/08/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 0% stake in Pandion Therapeutics, Inc. |
02/12/2021 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 31.6% stake in INNOVIVA, INC. |
12/07/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 6.4% stake in SPERO THERAPEUTICS, INC. |
12/07/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 8.9% stake in BICYCLE THERAPEUTICS PLC |
11/06/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 4.9% stake in TURNING POINT THERAPETUICS, INC. |
09/30/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 0% stake in PRINCIPIA BIOPHARMA INC. |
07/10/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/29/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/22/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/17/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 15.3% stake in THERAVANCE BIOPHARMA, INC. |
06/04/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 8.8% stake in SPERO THERAPEUTICS, INC. |
05/26/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 5.5% stake in TURNING POINT THERAPETUICS, INC. |
02/27/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 15.5% stake in THERAVANCE BIOPHARMA, INC. |
02/18/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/18/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 5% stake in MORPHIC HOLDING, INC. |
02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 1.1% stake in TRANSLATE BIO, INC. |
02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 10.1% stake in SPERO THERAPEUTICS, INC. |
02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 9.3% stake in PRINCIPIA BIOPHARMA INC. |
02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 10.7% stake in BICYCLE THERAPEUTICS PLC |
02/14/2020 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 1.8% stake in AILERON THERAPEUTICS, INC. |
|
|
|